Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study
Raymond Javan Chan,Reegan Knowles,Fredrick D Ashbury,Joanne Bowen,Alexandre Chan,Melissa Chin,Ian Olver,Carolyn Taylor,Stacey Tinianov,Paola Alberti,Paolo Bossi,Norman Brito-Dellan,Tim Cooksley,Gregory Brian Crawford,Niharika Dixit,Margaret I Fitch,Jason L Freedman,Pamela K Ginex,Nicolas H Hart,Daniel L Hertz,Michael Jefford,Bogda Koczwara,Tateaki Naito,Andrea Dahlman Orsey,Christina H Ruhlmann,Nikolaos Tsoukalas,Corina van den Hurk,Ysabella Van Sebille,Hannah Rose Wardill,Florian Scotte,Maryam Lustberg,Multinational Association of Supportive Care in Cancer (MASCC) Study Group Chairs
DOI: https://doi.org/10.1016/j.eclinm.2024.102825
IF: 15.1
2024-09-11
EClinicalMedicine
Abstract:Background: Supportive care to ensure optimal quality of life is an essential component of cancer care and symptom control across the lifespan. Ongoing advances in cancer treatment, increasing toxicity from many novel treatment regimes, and variations in access to care and cancer outcomes across the globe and resource settings present significant challenges for supportive care delivery. To date, no overarching framework has been developed to guide supportive care development worldwide. As an initial step of the Multinational Association of Supportive Care in Cancer (MASCC) Supportive Care 2030 Movement, we developed a targeted, unifying set of ambition statements to envision the future of supportive cancer care. Methods: From September 2022 until June 2023, we used a modified Delphi methodology to develop and attain consensus about ambition statements related to supportive cancer care. Leaders of MASCC Study Groups were invited to participate in an Expert Panel for the first two Delphi rounds (and a preliminary round to suggest potential ambition statements). Patient Advocates then examined and provided input regarding the ambition statements. Findings: Twenty-seven Expert Panelists and 11 Patient Advocates participated. Consensus was attained on 13 ambition statements, with two sub-statements. The ambition statements addressed global standards for guideline development and implementation, coordinated and individualized care, dedicated supportive oncology services, self-management, needs for screening and actions, patient education, behavioral support, financial impact minimization, comprehensive survivorship care, and timely palliative care, reflecting collaboration, coordination and team-based approach across all levels. Interpretation: This study is the first to develop shared ambitions for the future of supportive cancer care on a global level. These ambition statements can facilitate a coordinated, resource-stratified, and person-centered approach and inform research, education, clinical services, and policy efforts. Funding: This project received funding support from Prof Raymond Chan's NHMRC Investigator Grant (APP1194051).